It said its turnover stood at RON469.5 million, a similar level to that registered in the first half of 2019.
MedLife’s operating revenues stood at RON471.2 million in the first half, compared with RON472.1 million in the same period last year, while its operating profit grew 9.8% on the year, to RON30.8 million.
The group had total assets of RON1.04 billion at the end of June, up 2.7% compared with end-2019, while its total debts stood at RON825.8 million, up 1.7%.
MedLife clinics generated 30% of the group’s total sales, with RON142 million, up 1.6% on the year. The group’s hospitals generated sales of RON104.5 million in the first half, down 2.3% on the year.
The dental clinic segment generated revenues of RON25.4 million in the first half, down 11.6% on the year, while laboratories generated revenues of RON74.4 million, down 1.5%.
MedLife’s corporate sales stood at RON93.7 million in the first half, 3% higher on the year.
In the second half of the year, the company intends to continue investing in existing programs, but also to develop new projects and products post – COVID.
“We want to continue to invest, to expand, having at our disposal a new undrawn facility of EUR20 million announced in May this year, funds that will be used for the development of several projects in the context of COVID-19, as well as projects related to the area of prevention, research, refurbishment and not only, but also for the expansion of the M&A program, both nationally and internationally.(…) The new investments will proceed at a more slower pace, with a careful look at the reduction of costs and the evolution of the pandemic,” said MedLife CEO Mihai Marcu.